United European Gastroenterology Guideline: How to Manage Immunoglobulin G4-related Digestive Diseases

Overview

Journal United European Gastroenterol J

Publisher Wiley

Specialty Gastroenterology

Date 2020 Jul 7

PMID 32628896

Citations 1

Authors

Hiroyuki Matsubayashi

Kensuke Kubota

Affiliations

Soon will be listed here.

Citing Articles

Chen L, Almudaires A, AlZahrani M, Qumosani K, Chakrabarti S BMC Gastroenterol. 2021; 21(1):349.

PMID: 34544364 PMC: 8454001. DOI: 10.1186/s12876-021-01927-x.

References

Kamisawa T, Nakazawa T, Tazuma S, Zen Y, Tanaka A, Ohara H . Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2018; 26(1):9-42. PMC: 6590186. DOI: 10.1002/jhbp.596. View

Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N . Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995; 40(7):1561-8. DOI: 10.1007/BF02285209. View

Kawa S, Kamisawa T, Notohara K, Fujinaga Y, Inoue D, Koyama T . Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2018: Revision of Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2011. Pancreas. 2019; 49(1):e13-e14. PMC: 6946098. DOI: 10.1097/MPA.0000000000001443. View

Okazaki K . Autoimmune Pancreatitis and IgG4-Related Disease: The Storiform Discovery to Treatment. Dig Dis Sci. 2019; 64(9):2385-2394. DOI: 10.1007/s10620-019-05746-9. View

Notohara K, Kamisawa T, Uchida K, Zen Y, Kawano M, Kasashima S . Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey. J Gastroenterol. 2017; 53(7):845-853. DOI: 10.1007/s00535-017-1420-4. View

Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T . A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2011; 22(1):1-14. PMC: 3278618. DOI: 10.1007/s10165-011-0508-6. View

Kubota K, Kamisawa T, Okazaki K, Kawa S, Hirano K, Hirooka Y . Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients. J Gastroenterol. 2017; 52(8):955-964. DOI: 10.1007/s00535-016-1302-1. View

Matsubayashi H, Ishiwatari H, Imai K, Kishida Y, Ito S, Hotta K . Steroid Therapy and Steroid Response in Autoimmune Pancreatitis. Int J Mol Sci. 2020; 21(1). PMC: 6981453. DOI: 10.3390/ijms21010257. View

Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T . Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2019; 55(4):462-470. DOI: 10.1007/s00535-019-01658-7. View

10.

Lohr J, Beuers U, Vujasinovic M, Alvaro D, Frokjaer J, Buttgereit F . European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J. 2020; 8(6):637-666. PMC: 7437085. DOI: 10.1177/2050640620934911. View